tiprankstipranks
Trending News
More News >
Clinica Baviera, SA (ES:CBAV)
BME:CBAV

Clinica Baviera (CBAV) Stock Statistics & Valuation Metrics

Compare
8 Followers

Total Valuation

Clinica Baviera has a market cap or net worth of €831.48M. The enterprise value is €835.45M.
Market Cap€831.48M
Enterprise Value€835.45M

Share Statistics

Clinica Baviera has 16,307,580 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,307,580
Owned by Insiders
Owned by Institutions

Financial Efficiency

Clinica Baviera’s return on equity (ROE) is 0.39 and return on invested capital (ROIC) is 21.57%.
Return on Equity (ROE)0.39
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)21.57%
Return on Capital Employed (ROCE)0.30
Revenue Per Employee176.90K
Profits Per Employee25.17K
Employee Count1,706
Asset Turnover1.22
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Clinica Baviera is 19.3. Clinica Baviera’s PEG ratio is 4.33.
PE Ratio19.3
PS Ratio2.74
PB Ratio7.52
Price to Fair Value7.52
Price to FCF17.80
Price to Operating Cash Flow12.01
PEG Ratio4.33

Income Statement

In the last 12 months, Clinica Baviera had revenue of 301.78M and earned 42.94M in profits. Earnings per share was 2.58.
Revenue301.78M
Gross Profit60.54M
Operating Income60.54M
Pretax Income60.11M
Net Income42.94M
EBITDA84.53M
Earnings Per Share (EPS)2.58

Cash Flow

In the last 12 months, operating cash flow was 76.48M and capital expenditures -30.01M, giving a free cash flow of 46.47M billion.
Operating Cash Flow76.48M
Free Cash Flow46.47M
Free Cash Flow per Share2.85

Dividends & Yields

Clinica Baviera pays an annual dividend of €1.57, resulting in a dividend yield of 3.31%
Dividend Per Share€1.57
Dividend Yield3.31%
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.51
52-Week Price Change48.05%
50-Day Moving Average51.77
200-Day Moving Average45.49
Relative Strength Index (RSI)48.20
Average Volume (3m)2.20K

Important Dates

Clinica Baviera upcoming earnings date is Jul 28, 2026, TBA (Not Confirmed).
Last Earnings DateMar 4, 2026
Next Earnings DateJul 28, 2026
Ex-Dividend Date

Financial Position

Clinica Baviera as a current ratio of 1.26, with Debt / Equity ratio of 62.88%
Current Ratio1.26
Quick Ratio1.26
Debt to Market Cap<0.01
Net Debt to EBITDA0.22
Interest Coverage Ratio141.13

Taxes

In the past 12 months, Clinica Baviera has paid 17.18M in taxes.
Income Tax17.18M
Effective Tax Rate0.29

Enterprise Valuation

Clinica Baviera EV to EBITDA ratio is 10.01, with an EV/FCF ratio of 18.20.
EV to Sales2.80
EV to EBITDA10.01
EV to Free Cash Flow18.20
EV to Operating Cash Flow11.06

Balance Sheet

Clinica Baviera has €50.32M in cash and marketable securities with €69.16M in debt, giving a net cash position of -€18.84M billion.
Cash & Marketable Securities€50.32M
Total Debt€69.16M
Net Cash-€18.84M
Net Cash Per Share-€1.16
Tangible Book Value Per Share€4.26

Margins

Gross margin is 81.24%, with operating margin of 20.06%, and net profit margin of 14.23%.
Gross Margin81.24%
Operating Margin20.06%
Pretax Margin19.92%
Net Profit Margin14.23%
EBITDA Margin28.01%
EBIT Margin20.06%

Analyst Forecast

The average price target for Clinica Baviera is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score